text: Yo, check it out, I'm 'bout to drop some knowledge,
  This paper's objective is to evaluate the efficacy,
  Of modern antiemetic therapy, keepin' it real, you see?
  For chemotherapy-induced nausea and vomiting, that's the deal,
  For patients receiving multiple-day or high-dose chemotherapy, let's keep it real.
  
  The authors evaluated published phase II and phase III studies,
  And their personal experiences, no lies, no fallacies,
  To develop this consensus statement, they worked it out,
  They looked at the data, no room for doubt.
  
  The largest published experience, let me break it down,
  Is with 5-day cisplatin combination chemotherapy, renowned,
  5-HT3 antagonists came and changed the game,
  Improved emetic control, no more feeling lame.
  
  But hold up, day 4-5 nausea still causing strife,
  Delayed nausea and vomiting, messing up their life,
  Even with dexamethasone, it's still a clinical problem,
  We gotta find a solution, gotta evolve and solve 'em.
  
  A 5-HT3 antagonist plus dexamethasone, that's the way,
  The preferred option for patients, no delay,
  Receiving high-dose chemotherapy with stem cell transplant,
  We're tryin' to make it better, no need to rant.
  
  But here's the kicker, let me tell you the truth,
  The results ain't as successful for standard-dose chemotherapy, uncouth,
  We still got work to do, gotta keep pushin' ahead,
  Finding solutions, no time for rest, that's what I said.